Berlin, March 1, 2023 – Bayer has submitted an application to the Japanese Ministry of Health, Labor, and Welfare (MHLW) seeking approval of aflibercept 8 mg for the treatment of two major retinal diseases, neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME). The MHLW submission is based on positive results from both the phase III PULSAR trial in nAMD and the phase II/III PHOTON trial in DME…
Read More
Fakty Miami Top News:
- Asteroid that passes nearby could hit Earth in the future, NASA says
- Miranda Kerr’s KORA Organics: Here’s Why You’ll Love the Skincare Line
- Ukraine Says Drone Attack on Russian Airport Launched Inside Russia
- Judge jailing Banbury men’s murderers slams TikTok ‘fame’
- Flicking switch on Portland’s new generator | Mirage News
- Strengthen your relationship: Top 10 marriage counselling services in Singapore
- Android 14 uses “nonsensical” logic to calculate space usage on smartphones
- Thousands of Christians Condemn ‘Immoral’ MAGA Republican Budget Goals
Sunday, September 24